Anti-bacterial effects of Poly-N-Acetyl-glucosamine nanofibers in cutaneous wound healing: Requirement for Akt1

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Lindner, Haley Buff ^a   Zhang, Aiguo ^c   Eldridge, Juanita ^a   Demcheva, Marina ^b   Tsichilis, Philip ^d   Seth, Arun ^c   Vournakis, John ^b   Muise Helmericks, Robin C ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Marine Polymer Technologies Inc   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ANTIINFECTIVE AGENT; BETA DEFENSIN 3; N ACETYLGLUCOSAMINE; NANOFIBER; POLY N ACETYLGLUCOSAMINE; PROTEIN KINASE B; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT; BETA DEFENSIN; CYTOKINE; POLY N ACETYL GLUCOSAMINE; POLY-N-ACETYL GLUCOSAMINE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; GRAM STAINING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; INNATE IMMUNITY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN INJURY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UPREGULATION; WILD TYPE; WOUND HEALING; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; FLUORESCENCE MICROSCOPY; KINETICS; METABOLISM; METHODOLOGY; TRANSGENIC MOUSE;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

ACETYLGLUCOSAMINE; ANIMALS; ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; CYTOKINES; ENDOTHELIAL CELLS; KERATINOCYTES; KINETICS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; NANOFIBERS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; WOUND HEALING;

EID: 79955733974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018996     Document Type: Article

References (43)

1. Singer AJ, Clark RA, (1999) Cutaneous wound healing. N Engl J Med 341: 738-746.
2. Ganz T, (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720.
3. Huang HW, (2000) Action of antimicrobial peptides: two-state model. Biochemistry 39: 8347-8352.
4. Ganz T, Lehrer RI, (1994) Defensins. Curr Opin Immunol 6: 584-589.
5. Ganz T, (1987) Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun 55: 568-571.
6. Harder J, Bartels J, Christophers E, Schroder JM, (1997) A peptide antibiotic from human skin. Nature 387: 861.
7. Harder J, Bartels J, Christophers E, Schroder JM, (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276: 5707-5713.
8. Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, et al. (1999) Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 67: 2740-2745.
9. Ganz T, Rayner JR, Valore EV, Tumolo A, Talmadge K, et al. (1989) The structure of the rabbit macrophage defensin genes and their organ-specific expression. J Immunol 143: 1358-1365.
10. Hirsch JA, Reddy SA, Capasso WE, Linfante I, (2003) Non-invasive hemostatic closure devices: "patches and pads". Tech Vasc Interv Radiol 6: 92-95.
11. Palmer BL, Gantt DS, Lawrence ME, Rajab MH, Dehmer GJ, (2004) Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters. Am J Cardiol 93: 96-97.
12. Thatte HS, Zagarins S, Khuri SF, Fischer TH, (2004) Mechanisms of poly-N-acetyl glucosamine polymer-mediated hemostasis: platelet interactions. J Trauma 57: S13-21.
13. Pietramaggiori G, Yang HJ, Scherer SS, Kaipainen A, Chan RK, et al. (2008) Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/db mouse. J Trauma 64: 803-808.
14. Scherer SS, Pietramaggiori G, Matthews J, Perry S, Assmann A, et al. (2009) Poly-N-acetyl glucosamine nanofibers: a new bioactive material to enhance diabetic wound healing by cell migration and angiogenesis. Ann Surg 250: 322-330.
15. Fischer TH, Thatte HS, Nichols TC, Bender-Neal DE, Bellinger AD, et al. (2005) Synergistic platelet integrin signaling and factor XII activation in poly-N-acetyl glucosamine fiber-mediated hemostasis. Biomaterials 26: 5433-5443.
16. Fischer TH, Bode AP, Demcheva M, Vournakis JN, (2007) Hemostatic properties of glucosamine-based materials. J Biomed Mater Res A 80: 167-174.
17. Vournakis JN, Eldridge J, Demcheva M, Muise-Helmericks RC, (2008) Poly-N-acetyl glucosamine nanofibers regulate endothelial cell movement and angiogenesis: dependency on integrin activation of Ets1. J Vasc Res 45: 222-232.
18. Lavenburg KR, Ivey J, Hsu T, Muise-Helmericks RC, (2003) Coordinated functions of Akt/PKB and ETS1 in tubule formation. FASEB J 17: 2278-2280.
19. Watt FM, (1983) Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol 81: 100s-103s.
20. Selsted ME, Ouellette AJ, (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6: 551-557.
21. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL, (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522-526.
22. Oren A, Ganz T, Liu L, Meerloo T, (2003) In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 74: 180-182.
23. Hubert P, Herman L, Maillard C, Caberg JH, Nikkels A, et al. (2007) Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo. FASEB J 21: 2765-2775.
24. Garcia JR, Jaumann F, Schulz S, Krause A, Rodriguez-Jimenez J, et al. (2001) Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 306: 257-264.
25. Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, et al. (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127: 594-604.
26. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, et al. (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
27. Niyonsaba F, Ogawa H, Nagaoka I, (2004) Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111: 273-281.
28. Rohrl J, Yang D, Oppenheim JJ, Hehlgans T, (2010) Human {beta}-Defensin 2 and 3 and Their Mouse Orthologs Induce Chemotaxis through Interaction with CCR2. J Immunol.
29. Somanath PR, Chen J, Byzova TV, (2008) Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing. Angiogenesis 11: 277-288.
30. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, et al. (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16: 19-27.
31. Threadgill DW, Yee D, Matin A, Nadeau JH, Magnuson T, (1997) Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm Genome 8: 390-393.
32. Ganz T, (2004) Defensins: antimicrobial peptides of vertebrates. C R Biol 327: 539-549.
33. Aarbiou J, Verhoosel RM, Van Wetering S, De Boer WI, Van Krieken JH, et al. (2004) Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol 30: 193-201.
34. Yaneva M, Kippenberger S, Wang N, Su Q, McGarvey M, et al. (2006) PU.1 and a TTTAAA element in the myeloid defensin-1 promoter create an operational TATA box that can impose cell specificity onto TFIID function. J Immunol 176: 6906-6917.
35. Ma Y, Su Q, Tempst P, (1998) Differentiation-stimulated activity binds an ETS-like, essential regulatory element in the human promyelocytic defensin-1 promoter. J Biol Chem 273: 8727-8740.
36. Rieske P, Pongubala JM, (2001) AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain. J Biol Chem 276: 8460-8468.
37. Imler JL, Hoffmann JA, (2000) Signaling mechanisms in the antimicrobial host defense of Drosophila. Curr Opin Microbiol 3: 16-22.
38. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA, (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973-983.
39. Williams MJ, Rodriguez A, Kimbrell DA, Eldon ED, (1997) The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J 16: 6120-6130.
40. Hertz CJ, Wu Q, Porter EM, Zhang YJ, Weismuller KH, et al. (2003) Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol 171: 6820-6826.
41. Romano Carratelli C, Mazzola N, Paolillo R, Sorrentino S, Rizzo A, (2009) Toll-like receptor-4 (TLR4) mediates human beta-defensin-2 (HBD-2) induction in response to Chlamydia pneumoniae in mononuclear cells. FEMS Immunol Med Microbiol 57: 116-124.
42. Weichhart T, Saemann MD, (2008) The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis 67 (Suppl 3): iii70-74.
43. Mao C, Tili EG, Dose M, Haks MC, Bear SE, et al. (2007) Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. J Immunol 178: 5443-5453.